Audience: Of interest to anyone new to Health Technology Assessment (HTA) and Health Technology Management (HTM), including patients, students, policy-makers, health care professionals, and anyone attending the CADTH Symposium for the first time.
What you’ll learn: Participants will leave with an understanding of HTA and HTM, where they fit in the Canadian health care system, how they relate to other programs in the drug and medical devices spaces, opportunities to engage in HTA processes, and future trends.
- Don Husereau, University of Ottawa
Abstract: Attendees will gain a better understanding of what HTA and HTM are, become more familiar with key concepts and terminology, and learn the role of common analytic and deliberative approaches. Participants will be introduced to HTA and HTM principles and practices, including approaches to assess clinical effectiveness (benefits and harms), meta-analysis and modelling, cost-effectiveness, ethical issues, and organizational and implementation issues.
By the end of the workshop, participants will be able to describe the following:
- HTA and HTM, and their connection to health care decision-making/li>
- best practices in HTA and HTM
- best practices in assessing clinical effectiveness (benefits and harms) and cost-effectiveness
- approaches to assessing other aspects of the impact of technology and methods for integrating societal and stakeholder values
- best practices in deliberative approaches and creating and using recommendations.
To participate, please register (there is no cost). After registering, you will receive a confirmation email with information about how to join the webinar.